3,166
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

Consumption Patterns of Nightlife Attendees in Munich: A Latent-Class Analysis

, ORCID Icon &

References

  • Boiler, L., Voorham, L., Monshouwer, K., van Hasselt, N., & Bellis, M. (2011). Alcohol and drug prevention in nightlife settings: A review of experimental studies. Substance Use & Misuse, 46, 1569–1591.
  • Brunt, T. M., Nagy, C., Buecheli, A., Martins, D., Ugarte, M., Beduwe, C., & Vilamala, M. V. (2017). Drug testing in Europe: Monitoring results of the trans-European drug information (TEDI) project. Drug Testing and Analysis, 9, 188–198. doi:10.1002/dta.1954
  • Bühler, A., & Thrul, J. (2015). Prevention of addictive behaviours: Updated and expanded version of prevention of substance abuse. Lisbon, Portugal: European Monitoring Centre for Drugs and Drug Addiction.
  • Calafat, A., Bohrn, K., Juan, M., Kokkevi, A., Maalsté, N., Mendes, F., … Zavatti, P. (1999). Night life in Europe and recreative drug use. SONAR 98. Palma de Mallorca: IREFREA.
  • Calafat, A., & Juan, M. (2009). Preventive interventions in nightlife: A review. Addiciones, 21, 387–414.
  • Carlson, R. G., Wang, J., Falck, R. S., & Siegal, H. A. (2005). Drug use practices among MDMA/ecstasy users in Ohio: A latent class analysis. Drug and Alcohol Dependence, 79, 167–179.
  • Champion, K. E., Teesson, M., & Newton, N. C. (2015). Development of a universal internet-based prevention program for ecstasy and new psychoactive substances. Open Journal of Preventive Medicine, 5, 23–30.
  • Darke, S., Kaye, S., Ketin, R. M. C., & Duflou, J. (2008). Major physical and psychological harms of methamphetamine use. Drug and Alcohol Review, 27, 253–262.
  • Del Boca, F. K., & Darkes, J. (2003). The validity of self-reports of alcohol consumption: State of the science and challenges for research. Addiction, 98(Suppl. 2), 1–12.
  • Deluca, P., Davey, Z., Corazza, O., Di Furia, L., Farre, M., Flesland, L. H., … Schifano, F. (2012). Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 39, 221–226.
  • European Commission. (2014). Flash Eurobarometer 401: Young people and drugs. Brussels, Belgium: Author.
  • European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2010). The state of the drugs problem in Europe: Annual report 2010. Luxembourg: Office for Official Publications of the European Union.
  • European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2015). European drug report 2015: Trends and developments. Luxembourg: Publications Office of the European Union.
  • Fernández-Calderón, F., Bienestar, A., Josefa, D., Ortega, G., Vergara, E., González-Sáiz, F., & Bilbao, I. (2011). Polysubstance use patterns in underground rave attenders: A latent class analysis. Journal of Drug Education, 41, 183–202.
  • Gowing, L., Ali, R. L., Irvine, R. J., & Ali, R. L. (2002). The health effects of ecstasy: A literature review. Drug and Alcohol Review, 21, 53–63.
  • Hannemann, T.-V., & Piontek, D. (2015). Bewertung suchtpräventiver Partyprojekte durch Partygägner [Evaluation of addiction prevention projects in the nightlife by nightlife attendees] Munich, Germany: IFT Insitut für Therapieforschung.
  • Hibell, B., Guttormsson, U., Ahlström, S., Balakireva, O., Bjarnason, T., Kokkevi, A., & Kraus, L. (2011). The 2011 ESPAD report substance use among students in 36 European countries. Stockholm, Sweden: The Swedish Council for Information on Alcohol and other Drugs (CAN).
  • Hungerbuehler, I., Buecheli, A., & Schaub, M. (2011). Drug checking: A prevention measure for a heterogeneous group with high consumption frequency and polydrug use—Evaluation of Zurich's drug checking services. Harm Reduction Journal, 8, 16–21.
  • Kaye, S., Mcketin, R., Duflou, J., & Darke, S. (2007). Methamphetamine and cardiovascular pathology: A review of the evidence Methamphetamine and cardiovascular pathology: A review of the evidence. Addiction, 102, 1204–1211.
  • Kirkpatrick, M. G., Gunderson, E. W., Perez, A. Y., Haney, M., Foltin, R. W., & Hart, C. L. (2012). A direct comparison of the behavioral and physiological effects of methamphetamine and 3, 4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology, 219, 109–122.
  • Kraus, L., & Bauernfeind, R. (1997). Population survey on the consumption of psychoactive substances on the German adult population. Sucht, 44, 3–82.
  • Künzel, J., Kröger, C., Bühringer, G., Tauscher, M., & Walden, K. (1997). Repräsentative Befragung von Mitgliedern der Techno-Szene in Bayern: IFT-Bericht Bd. 94 [Representative survey of visitors of the techno-party-scene in Bavaria. IFT Report Vol. 94]. München, Germany: IFT Institut für Therapieforschung.
  • Lim, M. S. C., Hellard, M. E., Hocking, J. S., & Aitken, C. K. (2008). A cross-sectional survey of young people attending a music festival: associations between drug use and musical preference. Drug and Alcohol Review, 27, 439–441.
  • Luke, D. P., & Terhune, D. B. (2013). The induction of synaesthesia with chemical agents: A systematic review. Frontiers in Psychology, 4, 753–765.
  • Martinotti, G., Lupi, M., Carlucci, L., Cinosi, E., Santacroce, R., Acciavatti, T., … Di Giannantonio, M. (2015). Novel psychoactive substances: Use and knowledge among adolescents and young adults in urban and rural areas. Human Psychopharmacology: Clinical and Experimental, 30, 295–301.
  • Meyer, J. (2013). 3,4-Methylenedioxymethamphetamine (MDMA): Current perspectives. Substance Abuse and Rehabilitation, 4, 83–99.
  • Miller, P., Curtis, A., Jenkinson, R., Droste, N., Bowe, S. J., & Pennay, A. (2015). Drug use in Australian nightlife settings: Estimation of prevalence and validity of self-report. Addiction, 110, 1803–1810.
  • Móró, L. (2014). Harm reduction of novel psychoactive substance use. In G. R. Potter, M. Wouters, & J. Fountain (Eds.), Change and continuity: Researching evolving drug landscapes in Europe (pp. 36–50). Lengerich, Germany: Pabst Science Publishers.
  • Nichols, D. E. (2004). Hallucinogens. Pharmacology and Therapeutics, 101, 131–181.
  • Nutt, D. J., King, L. A., & Phillips, L. D. (2010). Drug harms in the UK: A multicriteria decision analysis. Lancet, 376, 1558–1565.
  • Nutt, D., King, L. A., Saulsbury, W., & Blakemore, C. (2007). Development of a rational scale to assess the harm of drugs of potential misuse. Lancet, 269, 1047–1053.
  • Pabst, A., Kraus, L., Gomes De Matos, E., & Piontek, D. (2013). Substance use and substance use disorders in Germany in 2012. Sucht, 59, 321–331.
  • Palamar, J. J., Martins, S. S., Su, M. K., & Ompad, D. C. (2015). Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting. Drug and Alcohol Dependence, 156, 112–119.
  • Parrott, A. C. (2015). Why all stimulant drugs are damaging to recreational users: An empirical overview and psychobiological explanation. Human Psychopharmacology: Clinical and Experimental, 30, 213–224.
  • Ramaswamy, V., DeSarbo, W. S., Reibstein, D. J., & Robinson, W. (1993). The empirical pooling approach for estimating marketing mix elasticities with PIMS data. Marketing Science, 12, 103–124.
  • Ramo, D. E., Grov, C., Delucchi, K., Kelly, B. C., & Parsons, J. T. (2010). Typology of club drug use among young adults recruited using time–space sampling. Drug and Alcohol Dependence, 107, 119–127.
  • Reynaud, M., Luquiens, A., Aubin, H., Talon, C., & Bourgain, C. (2013). Quantitative damage-benefit evaluation of drug effects: Major discrepancies between the general population, users and experts. Journal of Psychopharmacology, 27, 590–599.
  • Rogers, G., Elston, J., Garside, R., Roome, C., Taylor, R., Younger, P., … Somerville, M. (2009). The harmful health effects of recreational ecstasy: A systematic review of observational evidence. Health Technology Assessment, 13(5).
  • Stockings, E., Hall, W. D., Lynskey, M., Morley, K. I., Reavley, N., Strang, J., … Degenhardt, L. (2016). Prevention, early intervention, harm reduction, and treatment of substance use in young people. The Lancet Psychiatry, 3, 280–296.
  • Tossmann, P., Boldt, S., & Tensil, M.-D. (2001). The use of drugs within the techno party scene in European metropolitan cities. European Addiction Research, 7, 2–23.
  • Tourangeau, R., & Yan, T. (2007). Sensitive questions in surveys. Psychological Bulletin, 133, 859–883.
  • van Amsterdam, J., Opperhuizen, A., Koeter, M. W., & van den Brink, W. (2010). Ranking the harm of alcohol, tobacco and illicit drugs for the individual and the population. European Addiction Research, 16, 202–207.
  • van Amsterdam, J., Nutt, D., & Phillips, L. (2015). European rating of drug harms. Journal of Psychopharmacology, 29, 655–660.
  • van Havere, T., Vanderplasschen, W., Lammertyn, J., Broekaert, E., & Bellis, M. (2011). Drug use and nightlife: More than just dance music. Substance Abuse Treatment, Prevention, and Policy, 6, 18–28.
  • Vento, A. E., Martinotti, G., Cinosi, E., Lupi, M., Acciavatti, T., Carrus, D., … Schifano, F. (2014). Substance use in the club scene of Rome: A pilot study. BioMed Research International, 2014, article 617546.
  • Vincente, J., Olszewski, D., & Matias, J. (2008). Prevalence, patterns and trends of cannabis use among adults in Europe. In S. R. Sznitman, B. Olsson, & R. Room (Eds.), A cannabis reader: Global issues and locals experiences (Volume 2, pp. 3–28). Lisbon, Portugal: European Monitoring Centre for Drugs and Drug Addiction.
  • Werse, B., Kamphausen, G., Egger, D., Sravari, L., & Müller, D. (2015). MoSyD Jahresbericht 2014: Drogentrends in Frankfurt am Main [MoSyD Anual Report 2014: Trends in drug use in Frankfurt am Main]. Frankfurt am Main, Germany: Goethe-Universität, Institut für Sozialpädagogik und Erwachsenenbildung, Centre for Drug Research.
  • Werse, B., & Morgenstern, C. (2012). Abschlussbericht: Online-Befragung zum Thema “Legal Highs” [Final report: Online survey on the issue of “Legal Highs”]. Frankfurt am Main, Germany: Goethe-Universität, Institut für Sozialpädagogik und Erwachsenenbildung, Centre for Drug Research.
  • Werse, B., & Müller, O. (2010). Abschlussbericht: Spice, Smoke, Sence & Co. -Cannabinoidhaltige Räuchermischungen: Konsum und Konsummotivation vor dem Hintergrund sich wandelnder Gesetzesgebung [Final report: Spice, Smoke, Sence & Co.- Smoking mixtures containing cannabinoids: Consumption and consumption motivation against the background of changing legislation]. Frankfurt am Main, Germany: Goethe Universität, Insitut für Sozialpädagogik und Erwachsenenbildung, Centre for Drug Research.
  • Wiese, S., & Verthein, U. (2014). Drug-checking für drogenkonsumenten- risiken und potenziale. Sucht, 60, 315–322.
  • Zamengo, L., Frison, G., Bettin, C., & Sciarrone, R. (2014). Understanding the risks associated with the use of new psychoactive substances (NPS): high variability of active ingredients concentration, mislabelled preparations, multiple psychoactive substances in single products. Toxicology Letters, 229, 220–228.